Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neoadjuvant chemotherapy versus primary debulking surgery in advanced epithelial ovarian cancer: A meta-analysis of peri-operative outcome
Authors
Keywords
Surgical and invasive medical procedures, Meta-analysis, Surgical oncology, Gastrointestinal infections, Morbidity, Randomized controlled trials, Adverse events, Chemotherapy
Journal
PLoS One
Volume 12, Issue 10, Pages e0186725
Publisher
Public Library of Science (PLoS)
Online
2017-10-24
DOI
10.1371/journal.pone.0186725
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimal primary management of bulky stage IIIC ovarian, fallopian tube and peritoneal carcinoma: Are the only options complete gross resection at primary debulking surgery or neoadjuvant chemotherapy?
- (2017) Vasileios D. Sioulas et al. GYNECOLOGIC ONCOLOGY
- Patterns of Recurrence and Clinical Outcome of Patients With Stage IIIC to Stage IV Epithelial Ovarian Cancer in Complete Response After Primary Debulking Surgery Plus Chemotherapy or Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery
- (2017) Angiolo Gadducci et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602
- (2016) Takashi Onda et al. EUROPEAN JOURNAL OF CANCER
- Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome
- (2016) Anna Fagotti et al. EUROPEAN JOURNAL OF CANCER
- Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alexi A. Wright et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy for Patients with advanced epithelial ovarian cancer: A Meta-Analysis
- (2016) Long-Jia Zeng et al. Scientific Reports
- Neoadjuvant chemotherapy in gynaecological cancers – Implications for staging
- (2015) Lalit Kumar et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Appropriate Recommendations for Surgical Debulking in Stage IV Ovarian Cancer
- (2015) Jing-Yi Chern et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Primary Surgery or Interval Debulking for Advanced Epithelial Ovarian Cancer
- (2014) Algirdas Markauskas et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy
- (2014) Seiya Sato et al. Therapeutic Advances in Medical Oncology
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Primary debulking surgery or neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
- (2013) Hong Zheng et al. Chinese Journal of Cancer Research
- Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial
- (2013) Hannah S. van Meurs et al. EUROPEAN JOURNAL OF CANCER
- Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy
- (2013) Elfriede Greimel et al. GYNECOLOGIC ONCOLOGY
- Neoadjuvant chemotherapy with six cycles of carboplatin and paclitaxel in advanced ovarian cancer patients unsuitable for primary surgery: Safety and effectiveness
- (2013) Vanessa da Costa Miranda et al. GYNECOLOGIC ONCOLOGY
- Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study
- (2013) Carsten Lindberg Fagö-Olsen et al. GYNECOLOGIC ONCOLOGY
- A meta-analysis: neoadjuvant chemotherapy versus primary surgery in ovarian carcinoma FIGO stageIII and IV
- (2013) Ma Dai-yuan et al. World Journal of Surgical Oncology
- Comparison of Morbidity and Survival Between Primary and Interval Cytoreductive Surgery in Patients After Modified Posterior Pelvic Exenteration for Advanced Ovarian Cancer
- (2012) Aurélie Revaux et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Survival Rates for International Federation of Gynecology and Obstetrics Stage III Ovarian Carcinoma by Cell Type
- (2012) Jeffrey D. Seidman et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- 2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer
- (2011) Gavin C.E. Stuart et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic reviewers commonly contact study authors but do so with limited rigor
- (2008) Rebecca J. Mullan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now